GlassScriptPhysician profile
Hao N Thai
NPI 1194058255
$12,614.82
in general payments reported to CMS, 2019-2025
49 companies · $1,596 in 2025
The $1,596 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,857 · 2020: $1,496 · 2021: $2,185 · 2022: $1,102 · 2023: $1,255 · 2024: $1,123 · 2025: $1,596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,973.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,244.13 | 2019-2025 | Repatha, Evenity, Repatha |
| Novo Nordisk INC | $1,364.44 | 2019-2022 | |
| Gilead Sciences, INC. | $926.82 | 2019-2024 | Vemlidy |
| Astrazeneca Pharmaceuticals LP | $890.41 | 2019-2025 | Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $760.89 | 2019-2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $596.77 | 2019-2025 | Xifaxan, Trulance |
| Glaxosmithkline, LLC. | $588.15 | 2019-2023 | Arexvy, Bexsero, Shingrix |
| Mylan Specialty L.P. | $380.07 | 2022-2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $335.42 | 2021-2022 | |
| Amarin Pharma, INC. | $334.41 | 2019-2022 | |
| Lilly USA, LLC | $299.15 | 2019-2025 | Jardiance, Mounjaro |
| Nestle Healthcare Nutrition INC. | $280.45 | 2021-2023 | |
| Allergan, INC. | $259.67 | 2019 | |
| Pfizer INC. | $258.91 | 2019-2024 | |
| Optinose US, INC. | $252.63 | 2019-2020 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hao Thai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.